These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 28559996)
1. MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal. Guan J; Liu Z; Xiao M; Hao F; Wang C; Chen Y; Lu Y; Liang J Am J Transl Res; 2017; 9(5):2457-2465. PubMed ID: 28559996 [TBL] [Abstract][Full Text] [Related]
2. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. Wang Z; Ma X; Cai Q; Wang X; Yu B; Cai Q; liu B; Zhu Z; Li C FEBS Lett; 2014 Nov; 588(23):4504-12. PubMed ID: 25448600 [TBL] [Abstract][Full Text] [Related]
3. Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression. Liao K; Lin Y; Gao W; Xiao Z; Medina R; Dmitriev P; Cui J; Zhuang Z; Zhao X; Qiu Y; Zhang X; Ge J; Guo L Mol Ther Nucleic Acids; 2019 Dec; 18():388-399. PubMed ID: 31648104 [TBL] [Abstract][Full Text] [Related]
4. miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB. Liu Z; Wang C; Jiao X; Zhao S; Liu X; Wang Y; Zhang J Am J Transl Res; 2016; 8(11):4764-4777. PubMed ID: 27904678 [TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis. Xin Y; Zhang W; Mao C; Li J; Liu X; Zhao J; Xue J; Li J; Ren Y Onco Targets Ther; 2020; 13():1833-1844. PubMed ID: 32184618 [TBL] [Abstract][Full Text] [Related]
6. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133 [TBL] [Abstract][Full Text] [Related]
8. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545 [TBL] [Abstract][Full Text] [Related]
10. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway. Zeng B; Shi W; Tan G BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764 [TBL] [Abstract][Full Text] [Related]
11. LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis. Jin J; Xu H; Li W; Xu X; Liu H; Wei F Front Bioeng Biotechnol; 2020; 8():54. PubMed ID: 32133348 [TBL] [Abstract][Full Text] [Related]
12. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163 [TBL] [Abstract][Full Text] [Related]
13. MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma. Giovannini C; Fornari F; Dallo R; Gagliardi M; Nipoti E; Vasuri F; Coadă CA; Ravaioli M; Bolondi L; Gramantieri L Acta Histochem; 2018 Feb; 120(2):95-102. PubMed ID: 29249451 [TBL] [Abstract][Full Text] [Related]
14. microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4. Li Z; Zhou Y; Zhang L; Jia K; Wang S; Wang M; Li N; Yu Y; Cao X; Hou J Oncogenesis; 2020 Oct; 9(10):95. PubMed ID: 33099584 [TBL] [Abstract][Full Text] [Related]
15. Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expression. Shi Y; Song Q; Yu S; Hu D; Zhuang X Onco Targets Ther; 2015; 8():2303-10. PubMed ID: 26347410 [TBL] [Abstract][Full Text] [Related]
16. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
17. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]